IGF-1 DES

Description

Description

• 1 or 2 mg per vial variants
• Truncated IGF Analogue

Physical Form

• White lyophilized powder

Product Features

• Freeze-dried peptide in a sterile 2 mL vial
• Butyl rubber stopper provides multiple puncture access with a secure seal
• RTF vials are depyrogenated and ETO sterilized
• Tamper-evident aluminum flip top

Research Highlights

Enhanced Potency

• Lacks three amino acids at the N-terminal, reducing its affinity for IGF-binding proteins (IGFBPs). This structural feature allows for stronger receptor interaction and greater overall bioactivity compared to standard IGF-1.

Muscle & Connective Tissue Support

• Demonstrates potent anabolic properties even under reduced caloric intake, promoting muscle hypertrophy and aiding fibroblast function for potential wound-healing applications.

Neuroprotective Effects

• Shown to sustain neuron growth and synaptic integrity; investigated for neurological conditions ranging from autism to certain degenerative disorders such as ALS and Parkinson’s disease.

Metabolic Regulation

• May help regulate blood sugar levels with a rapid onset and short half-life, reflecting potential advantages in hyperglycemic and diabetic research models.

Immune Function & Cancer Research

• Studies suggest improvements in immune cell differentiation and activity. Preliminary findings also indicate a possible role in limiting undifferentiated cancer cell proliferation.